Free Daily Podcast Summary
TD Cowen Insights: Daily Summaries Delivered
by TD Securities, TD Cowen
Get key takeaways, quotes, and insights from TD Cowen Insights in a 5-minute read. Delivered straight to your inbox.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 1 weeks ago24 min
What Makes Mid-Size Banks So Interesting?
Recorded on 05/05/26 TD Cowen financial policy analyst Jaret Seiberg hosts TD Cowen's Two Cents Podcast, which this month features a conversation about mid-size banks with Janet Lee, TD Cowen's equity analyst who follows these companies. We also get a post-earnings season market update from TD Cowen specialty salesperson Scott Smith. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- 3 weeks ago28 min
Wellbeing, Longevity & Optimizing Healthspan With Mt. Sinai
Recorded on 03/09/26 The New Longevity Economy: A Biology-First Approach to Aging. We host Mount Sinai Healthspan Initiative Co-Director Zahi Fayad to discuss the shift from reactive sick care to proactive healthspan optimization at the high end. Key drivers include digital tools, advanced imaging, digital twins, continuous monitoring, and AI, reframing longevity as preserving vitality while compressing morbidity. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Apr 7, 202625 min
The New Budget Is Here! The New Budget Is Here!
Recorded on 04/06/26 In this episode, Roman Schweizer, TD Cowen’s WRG geopolitics & defense analyst, is joined by retired Major General Arnold Punaro to discuss the new Fiscal Year 2027 Federal Budget and Department of War $1.5 trillion budget request. They discuss the outlook for passage, plus a pending Operation Epic Fury war supplemental, as well as major components of the budget and surprises. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Apr 7, 202622 min
What's Happening With Alternative Investments?
Recorded on 04/06/26 TD Cowen financial policy analyst Jaret Seiberg hosts TD Cowen's Two Cents Podcast, which this month features a conversation about Alternative Investments with Bill Katz, TD Cowen's equity analyst, who follows asset managers, exchanges, and broker-dealers. We also get a pre-earnings season market update from TD Cowen specialty salesperson Scott Smith. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Apr 6, 202638 min
Saks Global's Next Act: Finance, Fashion, And Focus
Recorded on 03/20/26 Restructuring an Iconic Luxury Empire. We host Saks Global CEO Geoffroy van Raemdonck to discuss the company’s transformation following its Chapter 11 filing and committed capital. Key topics include restoring inventory flow, the importance of brand partners, and the evolution of the store footprint; and how loyalty, omnichannel engagement, and client-centric talent can drive durable profitability. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Mar 20, 202613 min
Bio-Techne at 50: CEO Kim Kelderman's Reflection on Five Decades of Platform Evolution & Strategic Priorities Ahead
Recorded on 03/03/26 TD Cowen life science & diagnostic tools analyst Kyle Boucher speaks with Bio-Techne CEO Kim Kelderman at TD Cowen's 46th Annual Health Care Conference to discuss Bio-Techne's 50-year anniversary, innovation and portfolio evolution, and growth pillars ahead. Since 1976 Bio-Techne has offered a wide range of critical reagents, assays, and analytical tools for customers in diagnostic, pharma, biotech, and academic settings, and has created one of the most consumables-focused portfolios in life science tools. CEO Kelderman reflects on Bio-Techne's 50-year history, including the last 10 years where the portfolio has grown through several inorganic acquisitions addressing multiple high-growth verticals that have laid the foundation for the next leg of growth. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Mar 20, 202611 min
CEO Meeker & CFO Smith's Strategy To Build Rhythm Into The Leading Orphan Obesity Company
Recorded on 03/01/26 TD Cowen senior biotech analyst Phil Nadeau speaks with Rhythm CEO David Meeker and CFO Hunter Smith at TD Cowen’s 46th Annual Health Care Conference to discuss Rhythm's strategic vision for establishing itself as the premier company in the orphan obesity space. Rhythm leverages the melanocortin pathway to address severe, early-onset obesity disorders, and its strategy is structured around three main pillars: genetic obesities, hypothalamic obesity (HO), and Prader-Willi syndrome. Building on the successful launch of Imcivree in Bardet-Biedl syndrome (BBS), Rhythm is now preparing for what may be its most significant launch to date: Imcivree for the treatment of hypothalamic obesity. Rhythm is optimistic that Imcivree will set a new standard of care for HO, significantly improve patient outcomes, and generate considerable value for shareholders. Beyond HO, Meeker and Smith outlined additional opportunities for Rhythm’s melanocortin-4 receptor (MC4R) agonists in other rare obesity disorders. These include ongoing investigations in various genetic obesity conditions as part of the Phase III EMANATE trial, as well as progress in Prader-Willi syndrome, where Imcivree demonstrated proof-of-concept efficacy in late 2025. To ensure the long-term success of the MC4R franchise, Rhythm is advancing a comprehensive life cycle management strategy, which includes the clinical development of next-generation MC4R agonists such as bivamelagon and RM-718. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
- Mar 18, 20266 min
FDA Engagement and the Evolving Psychedelic Therapy Landscape: A Conversation with Compass Pathways CEO Kabir Nath
Recorded on 03/03/26 TD Cowen senior biotech analyst Ritu Baral speaks with Compass CEO Kabir Nath at TD Cowen’s 46th Annual Health Care Conference. Discussion focused on FDA’s current approach to psychedelic drug development, what it signals for the broader psychiatry landscape, and the evolving interventional psychiatry infrastructure in the community setting. Nath highlights a highly engaged and collaborative FDA Psychiatry Division, noting the agency's recent acceptance of 7-8 psychedelic therapy INDs, and its willingness to work constructively with sponsors despite relatively small datasets in early development. He highlights recent positive psychedelic clinical datasets as many traditional antidepressant approaches continue to fall short, including Compass’s successful Phase 2 and 3 TRD results across three standardized studies as evidence of the category’s clinical potential. The conversation also explores how the existing interventional psychiatry infrastructure in the community setting, shaped in part by the successful launch of Spravato, has transformed the field and lowered barriers for future commercial uptake of innovative psychedelic therapies. With 7200+ certified Spravato treatment sites now in place and increasing familiarity with REMS-based models, Nath emphasizes the importance of bringing forward additional options in the psychedelic space to address significant unmet need across MDD, TRD, and PTSD as psychiatry treatment paradigms continue to evolve. https://go.td.com/PodcastDisclosure Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get TD Cowen Insights summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Insights & Indicators
Carlyle
In Good Companies
Cadence Bank
The CowShed Podcast
CowShed.
Insights Now
Dr. David Kelly and Gabriela Santos, J.P. Morgan Asset Management
Insights Now
PodClips
Capital Ideas Podcast
Capital Group
On the Couch
Marcus Today
Talking Billions with Bogumil Baranowski
Bogumil Baranowski
Biz Talk Today TV
Evergreen Podcasts | CrossCheck Media
WSJ's Take On the Week
The Wall Street Journal
Business Untitled
Business Untitled
The Rational Reminder Podcast
Benjamin Felix, Cameron Passmore, and Dan Bortolotti
About TD Cowen Insights
On each episode of "TD Cowen Insights", members of our firm host leading thinkers to share insights and ideas shaping the world economy. Join us, as we converse with the top minds who are influencing our global sectors.Disclosures: https://go.td.com/PodcastDisclosure
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from TD Cowen Insights in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's TD Cowen Insights daily summary?
It's a free AI-powered email that summarizes new episodes of TD Cowen Insights as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the TD Cowen Insights podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official TD Cowen Insights product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by TD Securities, TD Cowen.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
What topics does TD Cowen Insights cover?
TD Cowen Insights covers topics including Business. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting TD Cowen Insights summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.